Abstract
A 60-year-old man with intrahepatic cholangiocarcinoma (ICC) underwent a left hepatectomy. Following the procedure, S-1 was administered during the period of five months. About two years after the hepatectomy, the patient underwent a hepatic resection again for remunant hepatic recurrences of ICC. Aggressive surgical resection may be the only method to assure a good outcome. An indication of resection for the hepatic recurrence of ICC will be examined in the future.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antimetabolites, Antineoplastic / therapeutic use
-
Bile Duct Neoplasms
-
Bile Ducts, Intrahepatic
-
Cholangiocarcinoma / drug therapy
-
Cholangiocarcinoma / surgery*
-
Combined Modality Therapy
-
Deoxycytidine / analogs & derivatives
-
Deoxycytidine / therapeutic use
-
Drug Combinations
-
Gemcitabine
-
Hepatectomy*
-
Humans
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / surgery*
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Oxonic Acid / therapeutic use
-
Recurrence
-
Tegafur / therapeutic use
-
Tomography, X-Ray Computed
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
Deoxycytidine
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Gemcitabine